Nika Pharmaceuticals, Inc (NIKA) Return on Capital Employed (2022 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Return on Capital Employed came in at 44.71% in Q3 2023, up 638253562.0% YoY from N/an in Q3 2022, and up 2.62% on a QoQ basis from 43.57% in Q2 2023.
Nika Pharmaceuticals, Inc (NIKA) Return on Capital Employed (2022 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 2 years of Return on Capital Employed data on file, last reported at 44.71% in Q3 2023.
- Quarterly Return on Capital Employed rose 638253562.0% year-over-year to 44.71% in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 44.71% (up 638253562.0% YoY) and the FY2022 annual result came in at 18142.38%, changed N/A from the prior year.
- Return on Capital Employed improved to 44.71% in Q3 2023, from 43.57% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1997274.05% in Q2 2022 to a low of 6382490.91% in Q3 2022.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 44.71% |
| Jun 30, 2023 | 43.57% |
| Mar 31, 2023 | 8,163.25% |
| Dec 31, 2022 | 20,081.58% |
| Sep 30, 2022 | -6,382,490.91% |
| Jun 30, 2022 | 1,997,274.05% |